LENNOX GASTAUT SYNDROME (LGS)
Clinical trials for LENNOX GASTAUT SYNDROME (LGS) explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME (LGS) trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME (LGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart brain pacemaker aims to stop seizures while you sleep
Disease control Not yet recruitingThis early study will test a new way to use deep brain stimulation (DBS) in 4 adults with Lennox-Gastaut syndrome, a severe form of epilepsy. The device will automatically adjust stimulation based on whether the person is awake or asleep. Researchers want to see if this personali…
Matched conditions: LENNOX GASTAUT SYNDROME (LGS)
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Study tests safer switch from street CBD to approved drug for kids with severe epilepsy
Disease control Not yet recruitingThis study looks at the best way to switch children with Dravet or Lennox-Gastaut syndrome from artisanal (non-pharmaceutical) cannabidiol to Epidiolex, an FDA-approved CBD medication. About 25 children aged 2 to 18 will gradually increase their Epidiolex dose while reducing thei…
Matched conditions: LENNOX GASTAUT SYNDROME (LGS)
Phase: PHASE4 • Sponsor: Elizabeth Donner • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Wearable EEG gadget aims to perfect seizure drug dosing at home
Knowledge-focused Not yet recruitingThis study tests whether a wearable device that records brain waves, heart rate, and movement at home can help doctors better adjust the dose of the seizure drug fenfluramine for people with Dravet syndrome or Lennox-Gastaut syndrome. Twenty patients will wear the device for 3-7 …
Matched conditions: LENNOX GASTAUT SYNDROME (LGS)
Phase: NA • Sponsor: Byteflies • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC